Compliance Radar

Who was sanctioned, and for what?

Fines, court rulings and incidents from Europe and North America: 718 cases from 32 jurisdictions, each with an official source and checked against that source before publication. Filter by country, area of law and sector. Click a chart to drill down one level.

Capital markets and financial supervision Healthcare Clear all filters

1case from 1 jurisdiction

€166.7mTotal of monetary amounts

€166.7mLargest single case: Becton, Dickinson and Company (BD)

€166.7mMedian per case with an amount

Click a bar to drill down one level.

by amount by number of cases

Where?

by region

All jurisdictions

USA €166.7m 100 % · 1 case

What for?

by topic

Disclosure and reporting obligations €166.7m 100 % · 1 case

Who?

by company

Becton, Dickinson and Company (BD) €166.7m 100 % · 1 case

When?

per quarter, by date of decision

Trend
Period	Cases	Total
Q3 2023	0	—
Q4 2023	0	—
Q1 2024	0	—
Q2 2024	0	—
Q3 2024	0	—
Q4 2024	1	€166.7m
Q1 2025	0	—
Q2 2025	0	—
Q3 2025	0	—
Q4 2025	0	—
Q1 2026	0	—
Q2 2026	0	—
Q3 2026	0	—

1 case

Newest first Highest amounts

16 Dec 2024 Becton, Dickinson and Company (BD)Becton Dickinson: risks of Alaris infusion pump concealed – 175 million USD USADisclosure and reporting obligations €166.7m

The medical technology manufacturer misled investors about regulatory risks of the Alaris infusion pump, which had more than 25 software defects, and did not record the remediation costs, as a result of which operating income in the fourth quarter of 2019 was overstated by 82 %. BD is paying 175 million USD and must appoint an independent compliance consultant.

What organisations can take from it

Product and approval problems are capital market issues: quality and regulatory affairs departments must be involved in the disclosure process.

Authority / court: U.S. Securities and Exchange Commission (SEC)
Area of law: Capital markets and financial supervision · Disclosure and reporting obligations
Legal basis: Antifraud-, Reporting-, Buchführungs-, interne Kontroll- und Disclosure-Controls-Vorschriften der US-Wertpapiergesetze
Action: Fine
Status of proceedings: final
Sector: Healthcare

Original amount 175,000,000 USD, converted at the ECB reference rate of 16 Dec 2024.

Sources

Becton Dickinson to Pay $175 Million for Misleading Investors About Alaris Infusion Pump Press release of an authority

Checked against the official source on 25 Sep 2026 · Direct link

Report an error

How the radar is compiled

Official sources only

Every case is based on a decision, press release or database of an authority or a court. Press and law-firm reports count at most as additional references.

Four-eyes check

Whoever enters a case may not approve it. A second, independent check compares company, date, amount and area of law with the source. Only then is the case published.

Comparable amounts

Amounts are converted at the ECB reference rate on the day of the decision. Each case also shows the original amount.

Corrections on record

A correction is a new version that is checked again. Every change is logged. You can report errors directly on each case.

Case texts are translated from the German original. Where a translation is not yet available, the German text is shown and marked “(German original)”. Names of authorities, laws and companies are given as in the source.

The radar reports on published decisions and is not legal advice. Decisions that are not yet final are marked as such where the status is known.

Embed the radar on your website

Who was sanctioned, and for what?

Ready for training that sticks?